A Study of Patients Receiving Adjuvant Nivolumab Therapy for Melanoma That Has Been Removed

NCT03771859 · clinicaltrials.gov ↗
UNKNOWN
Status
152
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Bristol-Myers Squibb